flomoxef has been researched along with Escherichia coli Infections in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul Jabar, K; Abu Bakar, S; Ahmed Khan, A; Chong, CW; Harun, A; Ismail, Z; Jasni, AS; Karunakaran, R; Kong, ZX; Lau, MY; Lee, YQ; Leong, KC; Lim, VKE; Mak, ST; Masri, SN; Md Noor, SS; Mohd Taib, N; Ngoi, ST; Ponnampalavanar, S; Ramli, R; Salleh, SA; Tan, SC; Tee, LH; Teh, CSJ; Tengku Jamaluddin, TZM; Woon, JJ; Yap, PSX | 1 |
| Abe, Y; Fukuma, A; Hirade, T; Horie, A; Ito, T; Katou, F; Koike, D; Nariai, A; Saito, Y; Wakuri, M | 1 |
| Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Chan, KS; Chuang, YC; Kuo, CY; Tsai, CL; Yu, WL | 1 |
| Hiyama, E; Kodama, T; Sueda, T; Tsumura, H; Yokoyama, T | 1 |
| Iguro, Y; Matsumoto, H; Miyazaki, T; Taira, A; Yamashita, M | 1 |
| Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
| Ajiki, Y; Koga, T; Ohya, S; Takenouchi, T; Ueno, K; Watanabe, K; Yasuda, H | 1 |
1 trial(s) available for flomoxef and Escherichia coli Infections
| Article | Year |
|---|---|
[Postoperative infections in cardiovascular surgery: what is an appropriate prophylactic administration of antibiotics?].
Topics: Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cephalosporins; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Postoperative Care; Premedication; Staphylococcal Infections; Surgical Wound Infection | 1995 |
7 other study(ies) available for flomoxef and Escherichia coli Infections
| Article | Year |
|---|---|
A multicentre study to determine the
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Malaysia | 2023 |
Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; Cefmetazole; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Infant; Infant, Newborn; Male; O Antigens; Retrospective Studies; Urinary Tract Infections; Virulence | 2019 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
Early-onset septicemia due to CMY-2-producing Escherichia coli in a woman with blunt abdominal trauma.
Topics: Abdominal Injuries; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Sepsis; Taiwan | 2009 |
Relevance of antimicrobial agent-induced endotoxin release from in vitro cultured Escherichia coli and in vivo experimental infection with Gram-negative bacilli.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Monocytes; Peritonitis; Rabbits; Tumor Necrosis Factor-alpha | 2003 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefmetazole; Cephalosporins; Drug Resistance, Microbial; Escherichia coli Infections; Exudates and Transudates; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Substrate Specificity | 1991 |